Silvennoinen, R
Lundan, T
Kairisto, V
Pelliniemi, T-T
Putkonen, M
Anttila, P
Huotari, V
Mäntymaa, P
Siitonen, S
Uotila, L
Penttilä, T-L
Juvonen, V
Selander, T
Remes, K
Article History
Received: 24 August 2014
Accepted: 28 August 2014
First Online: 10 October 2014
Competing interests
: RS has received honoraria from Genzyme, Sanofi, Celgene and Janssen-Cilag, and research funding from Janssen-Cilag and Celgene; KR has received honoraria from Celgene and Janssen-Cilag; MP has received honoraria from Celgene; PA has received honoraria from Celgene and Janssen-Cilag; VK has received lecturing honoraria from Novartis and an educational grant from Novartis and Celgene; TTP has received educational grants from Celgene, Bristol-Myers-Squibb and Novartis; TL has received an educational grant from Bristol-Myers-Squibb; VJ has received an educational grant from Novartis and the remaining authors declare no conflict of interest.